Literature DB >> 16088748

Epidemiology of lung cancer with special reference to genetics, bioassays, women, and developing countries.

G P Page1, J L Green, D Lackland.   

Abstract

The twentieth century may be looked back upon as the century of lung cancer. At the beginning of the century lung cancer was quite rare, but this century the rates have increased approximately 10-fold and it is the second most common type of cancer and has become the leading cause of death due to cancer in the United States. The rate of lung cancer among U.S. women continues to rise, in contrast rates in U.S. men have been declining since about 1990. Cigarette smoking accounts for 85-90% of lung cancer deaths in the United States. However, only 10-15% of smokers eventually develop lung cancer. In the past 25 years, since the U.S. Surgeon General's ground breaking report in 1964, overall smoking rates have been declining, but smoking still remains a significant behavior. More troubling, the rates of smoking continue to increase in many parts of the world. Advances in molecular biology and early diagnosis have increased the understanding of lung cancer etiology and may be effective in uncovering more efficient detection and treatment regimens. These advances will hopefully make lung cancer as uncommon at the end of the twenty-first century, as it was at the beginning of the twentieth century.

Entities:  

Year:  2000        PMID: 16088748     DOI: 10.1055/s-2000-9403

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  3 in total

1.  Bilirubin Can Be Used as a Prognostic Factor for Lung Adenocarcinoma Patients with EGFR Mutations.

Authors:  Yimeng Geng; Yeling Mei; Ying Xi; Junlin Yu; Ke Meng; Tengfei Zhang; Wang Ma
Journal:  Onco Targets Ther       Date:  2020-10-29       Impact factor: 4.147

2.  Lung cancer in women: histological type and patient age from 1985 to 2005.

Authors:  Jelena Stojsic; Ivan Milovanovic; Jelena Radojicic; Branislava Milenkovic
Journal:  Med Oncol       Date:  2008-11-04       Impact factor: 3.064

3.  CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma.

Authors:  D'Anna N Mullins; Erin L Crawford; Sadik A Khuder; Dawn-Alita Hernandez; Youngsook Yoon; James C Willey
Journal:  BMC Cancer       Date:  2005-10-29       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.